4//SEC Filing
DeRose Kathleen 4
Accession 0001104659-21-133213
CIK 0001868912other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 6:09 PM ET
Size
6.6 KB
Accession
0001104659-21-133213
Insider Transaction Report
Form 4
Enfusion, Inc.ENFN
DeRose Kathleen
Director
Transactions
- Award
Class A Common Stock
2021-10-31+11,029→ 11,029 total - Award
Class A Common Stock
2021-10-31+5,515→ 16,544 total
Footnotes (2)
- [F1]Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units vest as follows: 3,676 RSUs on September 27, 2022; 3,676 RSUs on September 27, 2023; and 3,677 RSUs on September 27, 2024.
- [F2]Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units will vest in full on the date of the 2022 annual meeting of stockholders of the issuer.
Documents
Issuer
Enfusion, Inc.
CIK 0001868912
Entity typeother
Related Parties
1- filerCIK 0001792603
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 6:09 PM ET
- Size
- 6.6 KB